Whitebox Advisors’s Zura Bio Limited Warrants ZURAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-75,000
Closed -$30K 364
2024
Q2
$30K Hold
75,000
﹤0.01% 195
2024
Q1
$20.3K Hold
75,000
﹤0.01% 193
2023
Q4
$12.6K Hold
75,000
﹤0.01% 164
2023
Q3
$24.5K Hold
75,000
﹤0.01% 166
2023
Q2
$26.3K Hold
75,000
﹤0.01% 193
2023
Q1
$19.5K Hold
75,000
﹤0.01% 302
2022
Q4
$11.3K Hold
75,000
﹤0.01% 485
2022
Q3
$12K Hold
75,000
﹤0.01% 622
2022
Q2
$14K Hold
75,000
﹤0.01% 612
2022
Q1
$32K Hold
75,000
﹤0.01% 639
2021
Q4
$34K Buy
+75,000
New +$40.5K ﹤0.01% 661

Whitebox Advisors's ZURAW Position: Q3 2024 in Review

Whitebox Advisors sold out of Zura Bio Limited Warrants (ZURAW) in Q3 2024, closing a stake of 75,000 shares — an estimated $30K sold.

Whitebox Advisors first reported a position in ZURAW in Q4 2021 and held it in 11 quarters. The position peaked at $34K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZURAW as of Q3 2024.

  • Whitebox Advisors reported no remaining Zura Bio Limited Warrants position as of Q3 2024 after selling out during the quarter.
  • Whitebox Advisors sold 75,000 Zura Bio Limited Warrants shares in Q3 2024, an estimated $30K.
  • Whitebox Advisors first reported a position in Zura Bio Limited Warrants in Q4 2021 and held it in 11 quarters.
  • Whitebox Advisors's Zura Bio Limited Warrants position peaked at $34K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q3 2024.

Based on Whitebox Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.